Scientific and Medical Advisory Board (SMAB)

//Scientific and Medical Advisory Board (SMAB)
Scientific and Medical Advisory Board (SMAB) 2019-05-23T20:24:12+00:00

Scientific and Medical Advisory Board (SMAB)

The Scientific & Medical Advisory Board (SMAB) is established to provide the Board of Directors of the Carcinoid NeuroEndocrine Tumour Society of Canada (CNETS Canada) with independent, expert, multi-disciplinary, and strategic advice on the status of current and upcoming medical and scientific issues related to diagnosis, therapy and better management of treatment of NET patients. The SMAB will also assess and recommend potential medical and scientific partnerships and linkages that can advance the mandate of CNETS Canada. The CNETS Canada Board of Directors (the Board) will carefully assess all the recommendations of the SMAB but will retain the final authority and responsibilities for taking any decision pursuant to those recommendations.

2019 Scientific and Medical Advisory Board Members

Dr. Sylvia Asa
Dr. Sylvia Asa
Dr. Jean-Mathieu Beauregard
Dr. Jean-Mathieu Beauregard
Dr. Denise Chan
Dr. Denise Chan
Dr. Shereen Ezzat
Dr. Shereen EzzatCo-Chair
Dr. Rachel Goodwin
Dr. Rachel Goodwin
Dr. Julie Hallet
Dr. Julie Hallet
Dr. Cynthia Landry
Dr. Dean Ruether
Dr. Dean Ruether
Dr. Janice Pasieka
Dr. Janice Pasieka
Dr. Dean Ruether
Dr. Dean Ruether
Dr. Girish Shah
Dr. Girish Shah
Dr. Jean-Luc Urbain
Dr. Jean-Luc UrbainCo-Chair

Dr. Shereen Ezzat, Endocrine Oncologist (Co-Chair)

Dr. Jean-Luc Urbain, Nuclear Medicine (Co-Chair)

Dr. Sylvia Asa, Pathologist

Dr. Jean-Mathieu Beauregard, Nuclear Medicine

Dr. Denise Chan, Nuclear Medicine

Dr. Rachel Goodwin, Oncologist

Dr. Julie Hallet, Surgeon

Dr. Cynthia Landry, Primary Care Physician

Dr. Ozgur Mete, Pathologist

Dr. Janice Pasieka, Surgeon

Dr. Dean Ruether, Oncologist

Dr. Girish Shah, Researcher

Mandate of SMAB

The SMAB will provide advice on the following:

  • NET-related medical and scientific activities; their relevance and the quality of the science performed and used;

  • Emerging trends in medical and scientific issues pertaining to NETs: the challenges and opportunities in national and global contexts;

  • Knowledge translation and science communication activities;

  • Scientific and Clinical partnerships and linkages; and

  • The science underpinning of specific issues brought before the Board